These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7647425)

  • 1. From peptic ulcer disease to NSAID gastropathy. An evolving nosology.
    Roth SH
    Drugs Aging; 1995 May; 6(5):358-67. PubMed ID: 7647425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSAID gastropathy. A new understanding.
    Roth SH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1623-8. PubMed ID: 8694659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and NSAID induced gastropathy.
    Zeidler H
    J Rheumatol Suppl; 1991 Mar; 28():2-5. PubMed ID: 2038013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.
    Hawkey CJ
    Scand J Gastroenterol Suppl; 1996; 220():124-7. PubMed ID: 8898449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New understandings of NSAID gastropathy.
    Roth SH
    Scand J Rheumatol Suppl; 1989; 78():24-9; discussion 30-2. PubMed ID: 2660252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
    Bakowsky VS; Hanly JG
    J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis.
    Steen KS; Lems WF; Aertsen J; Bezemer D; Dijkmans BA
    Ann Rheum Dis; 2001 May; 60(5):443-7. PubMed ID: 11302864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drug gastropathy.
    Laine L
    Gastrointest Endosc Clin N Am; 1996 Jul; 6(3):489-504. PubMed ID: 8803564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAID gastropathy. The central issue.
    Roth SH
    Drugs; 1990; 40 Suppl 5():25-8. PubMed ID: 2081488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response.
    Roth SH; Bennett RE
    Arch Intern Med; 1987 Dec; 147(12):2093-100. PubMed ID: 3318750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.
    Griffin MR
    Am J Med; 1998 Mar; 104(3A):23S-29S; discussion 41S-42S. PubMed ID: 9572317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. An overview.
    Silverstein F
    Postgrad Med; 1991 May; 89(7):33-40. PubMed ID: 2031029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and economics of NSAID-induced gastropathy.
    Zeidler H
    Scand J Rheumatol Suppl; 1992; 92():3-8. PubMed ID: 1574686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins, NSAIDs, and cytoprotection.
    Wallace JL
    Gastroenterol Clin North Am; 1992 Sep; 21(3):631-41. PubMed ID: 1516961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healing and prevention of NSAID-induced peptic ulcers.
    Hawkey CJ
    Scand J Gastroenterol Suppl; 1994; 201():42-4. PubMed ID: 8047823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of gastropathy in destructive arthropathies.
    Hazleman BL
    Scand J Rheumatol Suppl; 1989; 78():1-4; discussion 30-2. PubMed ID: 2660251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis.
    Fries JF; Murtagh KN; Bennett M; Zatarain E; Lingala B; Bruce B
    Arthritis Rheum; 2004 Aug; 50(8):2433-40. PubMed ID: 15334455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.